Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection

Background Characterizing the prevalence and persistence of symptoms associated with COVID-19 infection following hospitalization and their impact is essential to planning post-acute community-based clinical services. This study seeks to identify persistent COVID-19 symptoms in patients 35 days post-hospitalization and their impact on quality of life, health, physical, mental, and psychosocial function. Methods and findings This prospective cohort study used the PROMIS® Instruments to identify symptoms and quality of life parameters in consecutively enrolled patients between March 22 and April 16, 2020, in New Jersey. The 183 patients (median age 57 years; 61.5% male, 54.1% white) reported persistent symptoms at 35 days, including fatigue (55.0%), dyspnea (45.3%), muscular pain (51%), associated with a lower odds rating general health (41.5%, OR 0.093 95% CI: 0.026, 0.329, p = 0.0002), quality of life (39.8%; OR 0.116 95% CI: 0.038, 0.364, p = 0.0002), physical health (38.7%, OR 0.055 95% CI: 0.016, 0.193, p <0.0001), mental health (43.7%, OR 0.093 95% CI: 0.021, 0.418, p = 0.0019) and social active role (38.7%, OR 0.095 95% CI: 0.031, 0.291, p<0.0001), as very good/excellent, particularly adults aged 65 to 75 years (OR 8·666 95% CI: 2·216, 33·884, p = 0·0019). Conclusions COVID-19 symptoms commonly persist to 35 days, impacting quality of life, health, physical and mental function. Early post-acute evaluation of symptoms and their impact on function is necessary to plan community-based services.